Physician profile

Piotr Wlodkowski

Cardiovascular Disease · Jacksonville, FL

NPI 1013413392

$4,362.61

in general payments reported to CMS, 2019-2025

17 companies · $1,578 in 2025

The $1,578 reported for 2025 was more than what 79% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$1,897.78
Travel and Lodging$1,758.97

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Cvrx, INC. $2,673.48 2024-2025 Barostim Neo System
Boston Scientific Corporation $595.94 2019-2024 Watchman Access System, Watchman Flx
Abbott Laboratories $395.53 2019-2025 Cardiomems, Thoratec Heartmate 3 Lvas Implant Kit
Abiomed $148.07 2024 Impella
Philips North America LLC $127.01 2022
Terumo Medical Corporation $67.43 2022-2023 Optitorque
Zoll Services LLC (A/K/A Zoll Lifecor Corp) $64.07 2023 Lifevest
Biosense Webster, INC. $43.54 2024 Nuvision Ice Catheter
Impulse Dynamics (USA) INC. $39.29 2023 Optimizer
Lexicon Pharmaceuticals, INC. $34.00 2023 Inpefa
Amgen INC. $31.04 2023 Repatha
Heartflow, INC. $28.54 2023 Ffrct
One Lambda, INC. $25.72 2025
Gentuity, LLC $25.44 2023 Vis-Rx, Gentuity Hf-Oct Imaging System
Scpharmaceuticals INC. $24.71 2024
Show all 17 companies
CompanyGeneral paymentsYearsTop products
Irhythm Technologies, INC. $24.63 2024 Zio Xt Patch, Zio Monitor
Cordis US Corp. $14.17 2024 Stabilizer

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Piotr Wlodkowski

$4,362.61

in general payments reported 2019-2025

Years
2019-2025
Top company
Cvrx, INC.
Context
The $1,578 reported for 2025 was more than what 79% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).

https://glasscript.com/doctor/7229831/piotr-wlodkowski

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.